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Abstract 
Background and Objectives: Congenital long QT syndrome (LQTS) predisposes affected 
individuals to ventricular tachycardia/fibrillation (VF/VF), potentially resulting in sudden cardiac 
death. The Tpeak – Tend interval and the Tpeak – Tend / QT ratio, electrocardiographic markers of 
dispersion of ventricular repolarization, were proposed for risk stratification but their predictive 
values in LQTS have been controversial. A systematic review and meta-analysis was conducted 
to examine the value of Tpeak – Tend intervals and Tpeak – Tend / QT ratios in predicting arrhythmic 
and mortality outcomes in congenital LQTS.  
Method: PubMed and Embase databases were searched until 9th May 2017, identifying 199 
studies.  
Results: Five studies on long QT syndrome were included in the final meta-analysis. Tpeak – Tend 
intervals were longer (mean difference [MD]: 13 ms, standard error [SE]: 4 ms, P = 0.002; I2 = 
34%) in congenital LQTS patients with adverse events [syncope, ventricular arrhythmias or 
sudden cardiac death] compared to LQTS patients without such events. By contrast, Tpeak – Tend / 
QT ratios were not significantly different between the two groups (MD: 0.02, SE: 0.02, P = 0.26; 
I2 = 0%). 
Conclusion: This meta-analysis showed that Tpeak – Tend interval is significant higher in 
individuals who are at elevated risk of adverse events in congenital LQTS, offering incremental 
value for risk stratification.  
Keywords: Tpeak – Tend; Tpeak – Tend / QT; dispersion of repolarization; risk stratification; 
ventricular arrhythmia; sudden cardiac death 
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Introduction 
Congenital long QT syndrome (LQTS) increases the risk of ventricular 
tachycardia/fibrillation (VT/VF), potentially leading to sudden cardiac death (SCD). However, 
patients with prolonged QT intervals are heterogeneous in that only a subset develop these 
adverse events, and risk stratification in this condition remains difficult. Traditional 
electrocardiographic markers for risk prediction have largely focused on abnormal 
repolarization, of which the archetypal examples are QT 1 and QTc 
2. Other markers 3, such as 
QT dispersion (QTd) 
4, 5, interval from the peak to the end of the T wave 6 (Tpeak – Tend interval) 
and Tpeak – Tend / QT ratio 7 were developed to improve risk stratification. 
Prolongation in the Tpeak – Tend interval increases arrhythmic risk because increased 
dispersion of repolarization predisposes to the occurrence of unidirectional block and therefore 
reentry 8-11. However, Tpeak – Tend varies with different species and heart rate, has significant 
inter-individual variability 12.  It was found that dividing it by the QT interval yielded a 
parameter, Tpeak – Tend / QT ratio, that had a relatively constant normal range between 0.17 and 
0.23 12. Much of the work on dispersion of repolarization were conducted by Yan and 
Antzelevitch in animal models and  electrocardiographic correlates of repolarization dispersion 
were subsequently used for risk stratification in humans 12. However, the predictive value of 
Tpeak – Tend interval or Tpeak – Tend / QT ratio in LQTS remains controversial. A recent meta-
analysis examined the prognostic value of Tpeak – Tend interval by pooling together the odds or 
hazard ratios for arrhythmic or mortality outcomes when this interval is prolonged, but it did not 
examine the absolute values of this index, nor did it investigate LQTS in the subgroup analyses 
13. Thus, many studies have reported Tpeak – Tend interval or Tpeak – Tend / QT ratio in LQTS. For 
Tpeak – Tend interval, three studies did not report a significant difference in duration between 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
LQTS patients who suffered from adverse events compared to those who did not 14, 15. For Tpeak – 
Tend / QT ratio was a significant predictor of torsade de pointes in univariate analysis, but lost its 
significance in multivariate analysis 16. By contrast, Tpeak – Tend / QT ratio was not significantly 
higher in LQTS patients who suffered from ventricular arrhythmias compared to LQTS patients 
without such events. Given these conflicting findings, the aim of this study is to conduct a 
systematic review with meta-analysis into the association between Tpeak – Tend interval and Tpeak 
– Tend / QT ratio and arrhythmic and/or mortality endpoints in LQTS. 
 
Methods 
Search strategy, inclusion and exclusion criteria 
This systematic review and meta-analysis was performed according to the Preferred 
Reporting Items for Systematic Reviews and eta-Analyses (PRISM) statement 17. PubMed and 
Embase were searched for studies that investigated the association between Tpeak – Tend or Tpeak – 
Tend / QT with arrhythmic or mortality endpoints in long QT syndrome. The following search 
terms were used for both databases: [“Tpeak–Tend” OR “Tp-Te” OR “Tpeak-end” OR “Tp-e” 
OR "T(peak)-T(end)" OR "T wave peak-to-end" OR "T peak-T end" OR “Tpe” "TPEc" OR "T-
peak to T-end" OR "Tpeak-to-Tend" AND "long QT"]. The search period was from the 
beginning of the database through to 9th May 2017 without language restrictions. The following 
inclusion criteria were used: i) the study was conducted on humans, ii) Tpeak – Tend intervals or 
Tpeak – Tend / QT ratios were provided; iii) endpoint events [appropriate implantable cardioverter-
defibrillator therapy (ICD), ventricular tachycardia/fibrillation (VT/VF), sudden cardiac death 
(SCD), cardiovascular death (CVD), major adverse cardiac events (MACE) or all-cause 
mortality were reported.  
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The quality assessment of these studies included in our meta-analysis was performed 
using the Newcastle–Ottawa Quality Assessment Scale (NOS) 18. The point score system 
evaluated the categories of study participant selection, comparability of the results, and quality of 
the outcomes. The following characteristics were assessed: a) representativeness of the exposed 
cohort; b) selection of the non-exposed cohort; c) ascertainment of exposure; d) demonstration 
that outcome of interest was not present at the start of study; e) comparability of cohorts based 
on study design or analysis; f) assessment of outcomes; g) follow-up periods that were 
sufficiently long for outcomes to occur; and h) adequacy of follow-up of cohorts. This scale 
varied from zero to nine stars, which indicated that studies were graded as poor quality if the 
score was <5, fair if the score was 5 to 7, and good if the score was >8. Studies with a score 
equal to or higher than six were included. The details of the NOS quality assessment are shown 
in Supplementary Tables 1 and 2. No studies were excluded based on the quality score. 
 
Data extraction and statistical analysis  
Data from the different studies were entered in pre-specified spreadsheets in Microsoft 
Excel. All potentially relevant studies were retrieved as complete manuscripts and assessed fully 
to determine whether they met the inclusion criteria. In this meta-analysis, the extracted data 
elements consisted of: i) publication details: last name of first author, publication year and 
locations; ii) study design; iii) endpoint(s); iv) the quality score; and v) the characteristics of the 
population including sample size, gender, age and number of subjects. Two reviewers (GT and 
CW) reviewed each included study independently. Disagreements were resolved by adjudication 
with input from a third reviewer (TL).  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
The endpoints of the studies are occurrences of ventricular arrhythmias (VT/VF), sudden 
cardiac death, cardiovascular death, major adverse cardiac events (MACE) or all-cause mortality. 
If more than one endpoint is described, then SCD is preferentially used for analysis, followed by 
cardiovascular death and all-cause mortality. Mean differences with 95% confidence interval 
(CI) for Tpeak – Tend interval and Tpeak – Tend/QT ratio were extracted from each study and 
subsequently pooled.  
The heterogeneity between studies was determined using Cochran's Q value, the 
weighted sum of squared differences between individual study effects and the pooled effect 
across studies, and the I2 statistic from the standard chi-square test, which describes the 
percentage of the variability in effect estimates resulting from heterogeneity, rather than 
sampling error. I2 > 50% was considered to reflect significant statistical heterogeneity. A fixed 
effects model was used if no significant heterogeneity was found. The random-effects model 
using the inverse variance heterogeneity method was used with I2 < 50%. To locate the origin of 
the heterogeneity, sensitivity analysis excluding one study at a time, and subgroup analyses 
based on different disease conditions and different endpoints were performed. Funnel plots, Begg 
and Mazumdar rank correlation test and Egger’s test were used to assess for possible publication 
bias. 
 
Results 
Figure 1 shows a flow diagram detailing the above search terms with inclusion and 
exclusion criteria. A total of 97 and 116 entries were retrieved from Pubmed and Embase, 
respectively. Five studies were relevant for congenital long QT syndrome (LQTS) and were 
included in our final meta-analysis 14, 15, 19-21. In this meta-analysis, a total of 388 patients were 
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included (mean age 35 years old, range from 7 to 38; 37% male). Table 1 shows the baseline 
characteristics of these studies and of the study populations. 
Regarding Tpeak – Tend intervals, two studies reported longer values in event-positive 
group compared to event-negative groups, whilst the remaining three studies demonstrated no 
significant prolongation (Figure 2). The Tpeak – Tend intervals for event-negative and event-
positive groups were 96 ± 8 and 114 ± 11, respectively, with a significant mean difference of 13 
± 4 ms (P = 0.002). The Cochran’s Q value was greater than the degrees of freedom (6 vs. 4), 
indicating that the true effect size was different between studies. I2 took a value of 34%, 
suggesting a low level of heterogeneity. A funnel plot plotting standard errors against differences 
in means is shown in Supplementary Figure 1. Begg and Mazumdar rank correlation analysis 
demonstrated that Kendall’s Tau took a value of 0.2 with P = 0.62, which suggests no significant 
publication bias. Egger’s test demonstrated no significant asymmetry (intercept 1.5, t-value 1.2; 
P = 0.32). To identify the source of the heterogeneity, sensitivity analysis was performed by 
removing one study at a time. However, this did not significantly influence the mean difference 
(Supplementary Figure 2), suggesting that no single study was responsible for the 
heterogeneity observed in this meta-analysis.  
For Tpeak – Tend / QT ratio, none of the four studies included in the analysis reported any 
significant difference between event-positive and event-negative groups (Figure 3). The Tpeak – 
Tend / QT ratio for event-negative and event-positive groups were 0.19 ± 0.01 and 0.21 ± 0.01, 
respectively, with no significant difference between the groups (mean difference: 0.02 ± 0.02; P 
= 0.26). The Cochran’s Q value was less than the degrees of freedom (0.2 vs. 3), indicating that 
the true effect size was not significantly different between the included studies. I2 took a value of 
0%, suggesting no heterogeneity. A funnel plot plotting standard errors against differences in 
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means is shown in Supplementary Figure 3. Begg and Mazumdar rank correlation analysis 
demonstrated that Kendall’s Tau took a value of 0 with P = 1.00, which suggests no publication 
bias. Egger’s test demonstrated no significant asymmetry (intercept 0.1, t-value 0.3; P = 0.81). 
To identify the source of the heterogeneity, sensitivity analysis was performed by removing one 
study at a time to calculate the pooled OR. However, this did not significantly influence the 
mean difference (Supplementary Figure 4), suggesting that no single study was responsible for 
the heterogeneity observed in this meta-analysis.  
 
Discussion 
Our main findings are that Tpeak – Tend intervals are longer and Tpeak – Tend / QT ratios are 
higher, in congenital LQTS patients suffering from adverse events compared to those who 
without these events.  
Pre-existing heterogeneities in the heart are crucial for ensuring unidirectional spread of 
action potentials conducted through the cardiac conduction system 22, 23. These are due to 
differences in repolarization times of the different cell types, which are responsible for 
inscription of the T-wave on the electrocardiogram (ECG) 24, 25. However, exacerbation of these 
heterogeneities has been linked to ventricular arrhythmogenesis in a variety of conditions. These 
include congenital ion channelopathies such as LQTS and Brugada syndrome 26-28, acquired 
causes of LQTS 29 and short QT syndrome 30, as well as other diseases such as diabetes mellitus, 
hypertension and myocardial infarction 31-34. These heterogeneities can occur locally or across 
the myocardial wall 35, potentially causing arrhythmias by inducing unidirectional conduction 
block and therefore circus-type or spiral wave re-entry 36, 37. Pre-clinical experiments have 
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associated higher degrees of transmural dispersion of repolarization (TDR) with 
arrhythmogenesis observed in long QT and Brugada syndromes 38, 39. 
A number of electrocardiographic indices have been developed for risk stratification 40, 41. 
The Tpeak – Tend interval was first proposed by Yan and Antzelevitch as an electrocardiographic 
surrogate marker of TDR 24, 42-44. This was based on observations in coronary-perfused wedge 
preparations, in which the end of repolarization of the epicardium coincided with the Tpeak and 
end of repolarization of M-cells coincided with Tend 
45. Subsequent experiments in pigs suggest 
that Tpeak coincided with the earliest end of repolarization and Tend coincided with the latest end 
of repolarization. However, given that the U-wave also represents the repolarizing current, Tend 
will likely reflect the majority of repolarization 46-48. Together, Tpeak – Tend is a surrogate marker 
for global  dispersion of repolarization 6, 9, 49, 50.  
In clinical studies, an increase in Tpeak – Tend interval has been associated with ventricular 
arrhythmias in LQTS type 1 and type 2 51, 52, Brugada syndrome 53 and other cardiac conditions 
such as myocardial infarction 54. Tpeak – Tend interval can be normalized to the QT interval, 
yielding Tpeak – Tend / QT ratio, which is equivalent to heart rate correction by Bazett's formula, 
with a relatively constant range of 0.17 to 0.23 12. This is thought to be a more sensitive index of 
arrhythmia risk than Tpeak – Tend interval, as it provides an estimate of dispersion of 
repolarization relative to total duration of repolarization, which would eliminate the confounding 
effects of heart rate and QT interval variability. Despite several studies have demonstrated the 
predictive value of Tpeak – Tend / QT ratio 12, 16, 32, 51, 55-57, three studies failed to demonstrate its 
value in LQTS and SQTS 16, 58, 59.  Only one of the included studies compared the performance 
of Tpeak – Tend intervals to traditional repolarization markers. Firstly, Samol and colleagues 
reported a sensitivity of 83% and a specificity of 73% at a cut-off value of 87ms with an area 
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under the curve (AUC) of 0.80±0.07) for the prediction of adverse clinical events by Tpeak – Tend 
20. This compared to a comparable sensitivity of 82% but lower specificity of 68% with AUC of 
0.86 ± 0.07 for QTc with a cut-off of 488 ms. It would appear that Tpeak – Tend has a higher 
specificity with similar sensitivity of discriminating high-risk patients when compared to QTc. 
These need to be confirmed by larger studies. More complex derivations of these repolarization 
intervals have been proposed 60, 61, but whether these provide incremental value for risk 
stratification is controversial 62, 63. 
However, incorporating conduction parameters into repolarization indices would likely 
improve risk stratification, since the likelihood of re-entry depends on both conduction velocity 
and refractory period, together determining the wavelength of excitation 64. This can be 
estimated electrocardiographically 40, 65, 66. Moreover, dispersion of conduction can predispose to 
unidirectional block. This can be observed as fragmentation in the QRS complex, whose 
prognostic value has been confirmed in Brugada syndrome 67. Fragmented QRS has been 
observed in LQTS 68, 69, but whether it will be useful as a risk marker remains to be evaluated 
prospectively.  
 
Limitations 
The following strengths should be noted. Firstly, this is the only meta-analysis to date 
analyzing the predictive of Tpeak – Tend intervals and Tpeak – Tend / QT ratios for adverse clinical 
outcomes in congenital LQTS. Secondly, only a small degree of heterogeneity for the meta-
analysis on mean difference of Tpeak – Tend intervals between event-positive and event-negative 
groups in congenital LQTS. This was despite different sub-types of congenital LQTS being 
included, suggesting that Tpeak – Tend intervals may be universally applicable regardless of the 
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underlying ion channel that is mutated. However, some limitations remain. Firstly, the 
percentage of male patients and age differed between the studies. As this was a study-level meta-
analysis, it was not possible to ascertain the impact of these factors on Tpeak – Tend intervals. 
Secondly, Tpeak – Tend intervals vary with lead positions and therefore measurement of these 
intervals from different leads can introduce a source of heterogeneity. Thirdly, their methods of 
determination, such as measurement from a single T-wave, averaged values of T-waves or 
median complexes, also differ. Fourthly, the definition of Tend also differs between studies. Three 
studies used the tangent method by taking the intersection of a tangent to the steepest downslope 
of the dominant repolarization wave with the isoelectric line, one study used the point at which 
the T-wave crossed the isoelectric line, and one study did not specify the method of Tend 
determination. Fifthly, there is considerable inter-observer variability. Interestingly, a previous 
study noted that for patients with LQTS, more than 80% of arrhythmia experts but less than 50% 
of cardiologists and less than 40% of non-cardiologists calculated the QTc correctly, and that 
interobserver agreement was excellent among QT experts, but moderate among arrhythmia 
experts and low among cardiologists and non-cardiologists 70. It also demonstrated 
underestimation of the QTc for LQTS patients and overestimation of this interval for healthy 
patients 70. Finally, recall bias may have been present in the retrospective studies, which could 
have also contributed to some of the heterogeneity observed. Nevertheless, the aim of this study 
is to determine the prognostic value of Tpeak – Tend intervals, which we have confirmed in our 
meta-analysis. 
 
Conclusions 
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This meta-analysis shows that Tpeak – Tend interval and Tpeak – Tend / QT ratio can 
distinguish high-risk patients with congenital LQTS from those who are at low-risk of adverse 
cardiac events. Further prospective studies with similarly definition of Tpeak – Tend interval from 
the same observers are needed to elucidate whether these indices provide additional value for 
risk stratification when compared to traditional repolarization indices such as the QTc interval. 
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Tables  
Table 1 Characteristics of the ten studies included in this meta-analysis 
First author 
/ Year 
Study design Population Lead for Tpeak – 
Tend measurement  
Method of Tend 
measurement 
Sample 
size (n) 
Age % 
Male 
Endpoints No. of 
patients 
with any 
positive 
events 
Syncope Ventricular 
arrhythmia 
SCA / 
SCD 
Reference 
Krych 2017 Retrospective Congenital 
LQT7 (KCNJ2) 
V2 or V3 Not specified 25 30 52 Syncope, CA, 
PVC > 2000 / 24 
hours, PVT, 
BiVT 
14 - - - 19 
Samol 2016 Prospective Congenital 
LQT1 
(KCNQ1), 2 
(KCNH2),8 
(CACNA1c) 
and unknown 
subtype 
V1 Tangent method 34 31 32 Syncope, TdP, 
SCA 
12 12 7 (TdP) 4 (SCA) 20 
Couderc 
2011 
Retrospective Drug-induced 
and congenital 
LQTS 
(KCNH2) 
II Tangent method 143 38 39 SCA, SCD 74 77 - 11 
(SCA), 3 
(SCD)  
15 
Couderc 
2010 
Retrospective Drug-induced 
and congenital 
LQTS (subtypes 
not described) 
All 12 leads Tangent method 8 7 63 TdP 5 - 5 - 14 
Kanters 
2008 
Retrospective Congenital 
LQT1 
(KCNQ1), 2 
(KCNH2), 3 
(SCN5A) 
V5 The point at 
which T-wave 
crosses isoelectric 
line 
95 37 34 Syncope  45 45 - - 21 
 
Abbreviations: LQT: long QT; CA: cardiac arrest; SCA: sudden cardiac arrest; SCD: Sudden cardiac death; ICD: implantable cardioverter-
defibrillator; PVC: premature ventricular complex; VT: Ventricular tachycardia; PVT: polymorphic VT; BiVT: bidirectional VT; 
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Figures  
Figure 1. Flow diagram of the study selection process. 
Figure 2. Forest plot demonstrating the mean differences for between Tpeak – Tend intervals 
obtained from event-positive and event-negative groups in LQTS. 
Figure 3. Forest plot demonstrating the mean differences for between Tpeak – Tend/QT ratios from 
in event-positive and event-negative groups in LQTS. 
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